Results of the summarizing process for the arXiv paper: 1201.2900v2

In the study conducted by Mikhail Peslyak, an analytical research was carried out to examine experimental and theoretical studies on the pathogenesis of psoriatic disease. As a result, a new model of pathogenesis was formulated with a focus on the skin's reaction to the systemic psoriatic process (SPP). The research suggests that psoriatic inflammation is triggered by Mo-R and DC-R cells in derma from blood flow containing Y-antigen. These cells can transform into mature maDC-Y and activate Y-specific T-lymphocytes in the process. This may be due to the presence of Y-antigen, a component of the interpeptide bridge IB-Y, which can be mistakenly interpreted as a sign of external PsB-infection by the skin immune system. This leads to mechanisms such as epidermal hyperproliferation as protection against bacterial infection. The initiation of psoriatic plaque is proposed to occur during local inflammatory processes in derma (LP2), triggering both innate and adaptive responses. This initiation can be linked to open trauma of derma or HPV-carriage of keratinocytes. The level of Y-priming, determined by the presence and concentration of Y-specific T-lymphocytes in prepsoriatic derma and lymph nodes, plays a crucial role in determining the possibility of psoriatic plaque formation. The severity and existence of plaques are influenced by the intensity of Y-antigen income into derma through Mo-R and DC-R. It is also suggested that severity of plaque can be exacerbated by LP2-inflammation if it persists after plaque initiation. New Mo-T, DC-T (including Mo-R, DC-R), and Y-specific T-lymphocytes are continuously drawn into plaques from blood flow, sustaining vicious cycles within the affected area. However, when there is a decrease in SPP severity, these cycles weaken and allow for natural remission or complete disappearance of plaques over time. The study also includes a detailed analysis comparing this new model with five previously published models on psoriasis pathogenesis. This comprehensive examination provides valuable insights into understanding the complex mechanisms underlying psoriatic disease progression and offers potential implications for future research and treatment strategies in this field.

• - Analytical research conducted by Mikhail Peslyak focused on pathogenesis of psoriatic disease
• - New model of pathogenesis formulated, emphasizing skin's reaction to systemic psoriatic process (SPP)
• - Psoriatic inflammation triggered by Mo-R and DC-R cells in derma from blood flow containing Y-antigen
• - Presence of Y-antigen can be mistakenly interpreted as external PsB-infection, leading to epidermal hyperproliferation
• - Initiation of psoriatic plaque linked to local inflammatory processes in derma (LP2), influenced by trauma or HPV-carriage
• - Level of Y-priming crucial in determining possibility of psoriatic plaque formation
• - Severity and existence of plaques influenced by intensity of Y-antigen income into derma through Mo-R and DC-R
• - Severity of plaque exacerbated by LP2-inflammation if it persists after initiation
• - Continuous influx of Mo-T, DC-T, and Y-specific T-lymphocytes into plaques sustains vicious cycles within affected area
• - Decrease in SPP severity weakens cycles, allowing for natural remission or disappearance of plaques over time
• - Detailed analysis comparing new model with five previously published models provides valuable insights into understanding complex mechanisms underlying psoriatic disease progression

SummaryMikhail Peslyak studied how psoriasis develops in the body. He found that skin reacts to a process happening inside the body, leading to inflammation. Certain cells in the skin trigger this inflammation when they encounter a specific substance called Y-antigen from the blood. Sometimes, the presence of this substance can be mistaken for an infection, causing skin cells to grow too quickly. The development of psoriasis patches on the skin is influenced by local inflammation and other factors like injuries or carrying certain viruses. Definitions- Analytical research: A type of study that involves examining something closely to understand it better. - Pathogenesis: The process by which a disease develops and progresses in the body. - Psoriatic disease: A chronic autoimmune condition that affects the skin, causing red, scaly patches. - Inflammation: The body's response to injury or infection, often resulting in redness, swelling, and pain. - Antigen: A substance that triggers an immune response in the body. - Epidermal hyperproliferation: Excessive growth of skin cells on the outer layer of the skin. - Plaque: Raised areas on the skin with a buildup of excess skin cells. - Lymphocytes: White blood cells that play a key role in the immune system's response to infections. - Remission: A period during which symptoms of a disease improve or disappear temporarily.

Psoriasis is a chronic autoimmune disease that affects the skin, causing red, scaly patches to form on various parts of the body. It is estimated that around 2-3% of the world's population suffers from psoriasis, making it a significant health concern. Despite its prevalence, the exact cause and mechanisms underlying this condition are still not fully understood. However, in recent years, researchers have made significant progress in unraveling the mysteries of psoriatic disease. One such study conducted by Mikhail Peslyak delves deep into understanding the pathogenesis of psoriasis. The research paper titled "New model of pathogenesis for psoriatic disease: focus on skin reaction to systemic process" provides valuable insights into how this complex disorder develops and progresses. The study begins by examining previous experimental and theoretical studies on psoriatic disease to identify gaps in knowledge and propose a new model for understanding its pathogenesis. The central focus of this new model is the skin's reaction to systemic psoriatic processes (SPP). According to Peslyak's research, inflammation in psoriasis is triggered by Mo-R and DC-R cells present in derma (the layer beneath the epidermis) from blood flow containing Y-antigen. Y-antigen is a component of interpeptide bridge IB-Y found in bacteria. In individuals with psoriasis, these cells can transform into mature maDC-Y cells and activate Y-specific T-lymphocytes – a type of white blood cell involved in immune responses – leading to an inflammatory response. This may be due to mistaken recognition of Y-antigen as a sign of external PsB-infection by the skin immune system. The initiation of psoriatic plaques – characteristic lesions seen in patients with psoriasis – occurs during local inflammatory processes (LP2) triggered by factors such as open trauma or human papillomavirus (HPV) infection carried by keratinocytes (skin cells). The level of Y-priming, determined by the presence and concentration of Y-specific T-lymphocytes in prepsoriatic derma and lymph nodes, plays a crucial role in determining the possibility of plaque formation. The severity and existence of plaques are influenced by the intensity of Y-antigen income into derma through Mo-R and DC-R. Additionally, if LP2-inflammation persists after plaque initiation, it can exacerbate the severity of plaques. This is because new Mo-T, DC-T (including Mo-R, DC-R), and Y-specific T-lymphocytes are continuously drawn into plaques from blood flow, creating vicious cycles within the affected area. However, as SPP severity decreases over time – either naturally or through treatment – these cycles weaken, allowing for remission or complete disappearance of plaques. This highlights the importance of targeting SPP in psoriasis treatment to disrupt these cycles and prevent disease progression. To support this new model, Peslyak provides a detailed analysis comparing it with five previously published models on psoriasis pathogenesis. This comprehensive examination not only strengthens his proposed model but also offers valuable insights into understanding the complex mechanisms underlying psoriatic disease progression. In conclusion, Mikhail Peslyak's research paper presents a novel model for understanding psoriatic disease that focuses on skin reactions to systemic processes. By identifying key players such as Mo-R and DC-R cells and their interactions with Y-specific T-lymphocytes in triggering inflammation and plaque formation, this study sheds light on potential targets for future treatments. Furthermore, its comparison with existing models provides a better understanding of this condition's complexity while offering potential implications for future research directions in this field.